# Peginterferon Beta-1a (BIIB017) Autoinjector Pharmacokinetic Study in Healthy Volunteers

> **NCT01610310** · PHASE1 · COMPLETED · sponsor: **Biogen** · enrollment: 55 (actual)

## Conditions studied

- Healthy
- Multiple Sclerosis

## Interventions

- **DEVICE:** BIIB017 (peginterferon beta-1a) Pre-filled syringe (PFS)
- **DEVICE:** BIIB017 (peginterferon beta-1a) Autoinjector

## Key facts

- **NCT ID:** NCT01610310
- **Lead sponsor:** Biogen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06
- **Primary completion:** 2012-10
- **Final completion:** 2012-10
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2014-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01610310

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01610310, "Peginterferon Beta-1a (BIIB017) Autoinjector Pharmacokinetic Study in Healthy Volunteers". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01610310. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*